OBJECTIVE: To study the prevalence of chronic kidney disease (CKD) [glomerular filtration rate (GFR) <60ml/min/1.73m(2)] and occult kidney disease (OKD) (normal serum creatinine values with GFR <60) in elderly patients. DESIGN: Retrospective, observational study. SETTING: Four primary care centres in the province of Huesca, Spain. PARTICIPANTS: About 4014 patients older than 65 years were randomly selected. MAIN MEASUREMENTS: GFR was calculated for all subjects using the four-variable modified MDRD equation. We registered all drugs prescriptions to the patients during a period of twelve months focusing on the potential nephrotoxic drugs. RESULTS: After exclusions, GFR was estimated in 3286 patients (1424 men of 75.49+/-6.6 years and 1862 women of 76.29+/-7.04 years; P=.001). The prevalence of CKD was 21.2%. A total of 10.1% of patients (12.8% of women and 6.44% of men) had OKD. We recorded the complete drug prescription in 269 patients. Mean of all different drugs that were prescribed by patient-year was 10.69+/-5.92 (men 9.55+/-5.57 and women 11.11+/-6; P=.05)]. A large number of patients were treated with potentially dangerous drugs, particularly the non-steroidal anti-inflammatory drugs with 165 cases (61.34%), and 72% were exposed to drugs that can lead to hyperkalaemia. CONCLUSIONS: We conclude that GFR estimation by clinical laboratories in the setting of primary care can contribute to prevent the adverse effects of inappropriate drug prescriptions.
OBJECTIVE: To study the prevalence of chronic kidney disease (CKD) [glomerular filtration rate (GFR) <60ml/min/1.73m(2)] and occult kidney disease (OKD) (normal serum creatinine values with GFR <60) in elderly patients. DESIGN: Retrospective, observational study. SETTING: Four primary care centres in the province of Huesca, Spain. PARTICIPANTS: About 4014 patients older than 65 years were randomly selected. MAIN MEASUREMENTS: GFR was calculated for all subjects using the four-variable modified MDRD equation. We registered all drugs prescriptions to the patients during a period of twelve months focusing on the potential nephrotoxic drugs. RESULTS: After exclusions, GFR was estimated in 3286 patients (1424 men of 75.49+/-6.6 years and 1862 women of 76.29+/-7.04 years; P=.001). The prevalence of CKD was 21.2%. A total of 10.1% of patients (12.8% of women and 6.44% of men) had OKD. We recorded the complete drug prescription in 269 patients. Mean of all different drugs that were prescribed by patient-year was 10.69+/-5.92 (men 9.55+/-5.57 and women 11.11+/-6; P=.05)]. A large number of patients were treated with potentially dangerous drugs, particularly the non-steroidal anti-inflammatory drugs with 165 cases (61.34%), and 72% were exposed to drugs that can lead to hyperkalaemia. CONCLUSIONS: We conclude that GFR estimation by clinical laboratories in the setting of primary care can contribute to prevent the adverse effects of inappropriate drug prescriptions.
Authors: Edmund J Lamb; Michelle C Webb; David E Simpson; Anthony J Coakley; David J Newman; Shelagh E O'Riordan Journal: J Am Geriatr Soc Date: 2003-07 Impact factor: 5.562
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Adam T Whaley-Connell; James R Sowers; Lesley A Stevens; Samy I McFarlane; Michael G Shlipak; Keith C Norris; Shu-Cheng Chen; Yang Qiu; Changchun Wang; Suying Li; Joseph A Vassalotti; Allan J Collins Journal: Am J Kidney Dis Date: 2008-04 Impact factor: 8.860
Authors: Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan Journal: Ann Intern Med Date: 2003-07-15 Impact factor: 25.391
Authors: Lesley A Stevens; Josef Coresh; Harold I Feldman; Tom Greene; James P Lash; Robert G Nelson; Mahboob Rahman; Amy E Deysher; Yaping Lucy Zhang; Christopher H Schmid; Andrew S Levey Journal: J Am Soc Nephrol Date: 2007-09-12 Impact factor: 10.121
Authors: C A Jones; G M McQuillan; J W Kusek; M S Eberhardt; W H Herman; J Coresh; M Salive; C P Jones; L Y Agodoa Journal: Am J Kidney Dis Date: 1998-12 Impact factor: 8.860
Authors: G Fernández-Fresnedo; A L M de Francisco; E Rodrigo; C Piñera; I Herráez; J C Ruiz; M Arias Journal: Nefrologia Date: 2002 Impact factor: 2.033
Authors: Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs Journal: PLoS One Date: 2016-07-06 Impact factor: 3.240